Nada Roumany Ghobrial, PHARMD | |
26520 Cactus Ave, Moreno Valley, CA 92555-3927 | |
(951) 486-4000 | |
Not Available |
Full Name | Nada Roumany Ghobrial |
---|---|
Gender | Female |
Speciality | Pharmacist - Pharmacotherapy |
Location | 26520 Cactus Ave, Moreno Valley, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306238415 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P1200X | Pharmacist - Pharmacotherapy | 64683 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nada Roumany Ghobrial, PHARMD 43121 Calle Ventura, Temecula, CA 92592-3118 Ph: (310) 779-5963 | Nada Roumany Ghobrial, PHARMD 26520 Cactus Ave, Moreno Valley, CA 92555-3927 Ph: (951) 486-4000 |
News Archive
Liz Lucas got a call Tuesday afternoon from a friend she'd interacted with closely at a journalism conference in New Orleans days earlier who had tested presumptively positive for coronavirus. She wondered what this meant for her and those around her, so she reached out to local and state health officials in Missouri for guidance.
People who enjoy life maintain better physical function in daily activities and keep up faster walking speeds as they age, compared with people who enjoy life less, according to a new study in CMAJ.
Immunoglobulin E (IgE) is the main actor in the drama of allergy. The biological role of IgE in the immune response of an organism and the lack of control leading to allergy is the research topic of Gernot Achatz, Molekular Biology, University of Salzburg. At the 2nd European Congress of Immunology ECI 2009 held in Berlin the scientist presents new data revealing the evolution of IgE.
ValueOptions, the nation's largest independent behavioral health and wellness company, and LifeWIRE announced today a joint teaming agreement to create a mobile monitoring, intervention and counseling program.
Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging its molecular adhesion and sealant technology (MAST) platform to develop novel therapies for sickle cell disease, heart failure, and arterial disease, today reported that it has initiated an open-label, multicenter Phase 3 extension study of vepoloxamer (MST-188) in sickle cell disease, referred to as "EPIC-E."
› Verified 9 days ago
Osama Bishay, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24991 Alessandro Blvd, Moreno Valley, CA 92553 Phone: 951-485-4450 | |
Dr. Thu Kieu Nguyen Huynh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4613 | |
Hong My Lam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12275 Perris Blvd, Moreno Valley, CA 92557 Phone: 951-242-8717 | |
Grace Shinn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 | |
Dr. Chi Wah Simon Chou, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25011 Alessandro Blvd, Moreno Valley, CA 92553 Phone: 951-485-1116 | |
Oksana Niknafs, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4515 | |
Dr. Linda Tang Ortega, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23965 Ironwood Ave, Moreno Valley, CA 92557 Phone: 951-242-1742 Fax: 951-242-7291 |